298 related articles for article (PubMed ID: 22036866)
1. Why do anti-inflammatory therapies fail to improve insulin sensitivity?
Gao ZG; Ye JP
Acta Pharmacol Sin; 2012 Feb; 33(2):182-8. PubMed ID: 22036866
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and insulin resistance.
Shoelson SE; Lee J; Goldfine AB
J Clin Invest; 2006 Jul; 116(7):1793-801. PubMed ID: 16823477
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
4. Inflammation during obesity is not all bad: evidence from animal and human studies.
Ye J; McGuinness OP
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E466-77. PubMed ID: 23269411
[TBL] [Abstract][Full Text] [Related]
5. Macrophages, immunity, and metabolic disease.
McNelis JC; Olefsky JM
Immunity; 2014 Jul; 41(1):36-48. PubMed ID: 25035952
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance.
Ye L; Liang S; Guo C; Yu X; Zhao J; Zhang H; Shang W
Life Sci; 2016 Dec; 166():82-91. PubMed ID: 27702567
[TBL] [Abstract][Full Text] [Related]
7. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.
Oliver E; McGillicuddy F; Phillips C; Toomey S; Roche HM
Proc Nutr Soc; 2010 May; 69(2):232-43. PubMed ID: 20158940
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
Esser N; Paquot N; Scheen AJ
Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the evidence for macrophage presence in skeletal muscle and its relation to insulin resistance in obese mice and humans: a systematic review protocol.
Bhatt M; Rudrapatna S; Banfield L; Bierbrier R; Wang PW; Wang KW; Thabane L; Samaan MC
BMC Res Notes; 2017 Aug; 10(1):374. PubMed ID: 28789665
[TBL] [Abstract][Full Text] [Related]
10. An update on immune dysregulation in obesity-related insulin resistance.
Daryabor G; Kabelitz D; Kalantar K
Scand J Immunol; 2019 Apr; 89(4):e12747. PubMed ID: 30593678
[TBL] [Abstract][Full Text] [Related]
11. The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.
Wensveen FM; Valentić S; Šestan M; Turk Wensveen T; Polić B
Eur J Immunol; 2015 Sep; 45(9):2446-56. PubMed ID: 26220361
[TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes.
Kuryłowicz A; Koźniewski K
Molecules; 2020 May; 25(9):. PubMed ID: 32397353
[TBL] [Abstract][Full Text] [Related]
13. IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.
Ballak DB; Stienstra R; Tack CJ; Dinarello CA; van Diepen JA
Cytokine; 2015 Oct; 75(2):280-90. PubMed ID: 26194067
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle inflammation and insulin resistance in obesity.
Wu H; Ballantyne CM
J Clin Invest; 2017 Jan; 127(1):43-54. PubMed ID: 28045398
[TBL] [Abstract][Full Text] [Related]
15. Role of immune cells in obesity induced low grade inflammation and insulin resistance.
Asghar A; Sheikh N
Cell Immunol; 2017 May; 315():18-26. PubMed ID: 28285710
[TBL] [Abstract][Full Text] [Related]
16. Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes.
Ye J
Front Med; 2015 Jun; 9(2):139-45. PubMed ID: 25511621
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice.
Foryst-Ludwig A; Hartge M; Clemenz M; Sprang C; Hess K; Marx N; Unger T; Kintscher U
Cardiovasc Diabetol; 2010 Oct; 9():64. PubMed ID: 20955583
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to target inflammation in type 2 diabetes.
Goldfine AB; Fonseca V; Shoelson SE
Clin Chem; 2011 Feb; 57(2):162-7. PubMed ID: 21098138
[TBL] [Abstract][Full Text] [Related]
19. Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.
Goran MI; Alderete TL
Nestle Nutr Inst Workshop Ser; 2012; 73():49-60; discussion p61-6. PubMed ID: 23128765
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
